BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38598874)

  • 1. Prognostic impact of positive microscopic margins (R1 resection) in patients with GIST (gastrointestinal stromal tumours): Results of a multicenter European study.
    Thibaut F; Veziant J; Warlaumont M; Gauthier V; Lefèvre J; Gronnier C; Bonnet S; Mabrut JY; Regimbeau JM; Benhaim L; Tiberio GAM; Mathonnet M; Regenet N; Chirica M; Glehen O; Mariani P; Panis Y; Genser L; Mutter D; Théreaux J; Bergeat D; Le Roy B; Brigand C; Eveno C; Guillaume P;
    Eur J Surg Oncol; 2024 Jun; 50(6):108310. PubMed ID: 38598874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between R1 resection, tumour rupture and recurrence in resected gastrointestinal stromal tumour.
    Hølmebakk T; Bjerkehagen B; Hompland I; Stoldt S; Boye K
    Br J Surg; 2019 Mar; 106(4):419-426. PubMed ID: 30507040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do microscopic surgical margins matter for primary gastric gastrointestinal stromal tumor?
    Shannon AB; Song Y; Fraker DL; Roses RE; DeMatteo RP; Miura JT; Karakousis GC
    Surgery; 2021 Feb; 169(2):419-425. PubMed ID: 32863011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wide Surgical Margin Improves the Outcome for Patients with Gastrointestinal Stromal Tumors (GISTs).
    Åhlén J; Karlsson F; Wejde J; Nilsson IL; Larsson C; Bränström R
    World J Surg; 2018 Aug; 42(8):2512-2521. PubMed ID: 29435627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician Underestimation of the Risk of Gastrointestinal Stromal Tumor Recurrence After Resection.
    Guérin A; Sasane M; Keir CH; Gauthier G; Macalalad AR; Wu EQ; Conley AP
    JAMA Oncol; 2015 Sep; 1(6):797-805. PubMed ID: 26204106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of clinical features and prognostic factors on reoperation patients with postoperative recurrence or metastasis of gastrointestinal stromal tumor].
    Wang L; Xu W; Yao X; Yan C; Li C; Zhu Z; Liu W; Yan M
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1274-1279. PubMed ID: 30506539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between R1 resection and oncological outcome in resectable gastrointestinal stromal tumors without tumor rupture: A systematic review and meta-analysis.
    Kong M; Liu G; Zhuo H; Xin Y; Chen H; Sheng H; Li L
    Eur J Surg Oncol; 2021 Jul; 47(7):1526-1534. PubMed ID: 33573855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour - the impact of tumour rupture on patient outcomes.
    Rutkowski P; Bylina E; Wozniak A; Nowecki ZI; Osuch C; Matlok M; Switaj T; Michej W; Wroński M; Głuszek S; Kroc J; Nasierowska-Guttmejer A; Joensuu H
    Eur J Surg Oncol; 2011 Oct; 37(10):890-6. PubMed ID: 21737227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microscopically positive margins for primary gastrointestinal stromal tumors: analysis of risk factors and tumor recurrence.
    McCarter MD; Antonescu CR; Ballman KV; Maki RG; Pisters PW; Demetri GD; Blanke CD; von Mehren M; Brennan MF; McCall L; Ota DM; DeMatteo RP;
    J Am Coll Surg; 2012 Jul; 215(1):53-9; discussion 59-60. PubMed ID: 22726733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts.
    Joensuu H; Vehtari A; Riihimäki J; Nishida T; Steigen SE; Brabec P; Plank L; Nilsson B; Cirilli C; Braconi C; Bordoni A; Magnusson MK; Linke Z; Sufliarsky J; Federico M; Jonasson JG; Dei Tos AP; Rutkowski P
    Lancet Oncol; 2012 Mar; 13(3):265-74. PubMed ID: 22153892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic role of microscopically positive margins for primary gastrointestinal stromal tumors: a systematic review and meta-analysis.
    Zhi X; Jiang B; Yu J; Røe OD; Qin J; Ni Q; Sun L; Xu M; Zhu J; Ma L
    Sci Rep; 2016 Feb; 6():21541. PubMed ID: 26891953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological Features and Prognosis of Primary GISTs with Tumor Rupture in the Real World.
    Nishida T; Cho H; Hirota S; Masuzawa T; Chiguchi G; Tsujinaka T;
    Ann Surg Oncol; 2018 Jul; 25(7):1961-1969. PubMed ID: 29752602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical pathological features and prognosis analysis of gastrointestinal stromal tumor: a series of 558 cases].
    Yang J; Yu J; Ma Z; Kang W; Tian S; Ye X
    Zhonghua Wai Ke Za Zhi; 2015 Apr; 53(4):274-9. PubMed ID: 26269161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant Imatinib.
    Gronchi A; Bonvalot S; Poveda Velasco A; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson IR; Italiano A; Gelderblom HJ; van Coevorden F; Penel N; Kopp HG; Duffaud F; Goldstein D; Broto JM; Wardelmann E; Marréaud S; Smithers M; Le Cesne A; Zaffaroni F; Litière S; Blay JY; Casali PG
    JAMA Surg; 2020 Jun; 155(6):e200397. PubMed ID: 32236507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is multivisceral resection in locally advanced gastrointestinal stromal tumours an acceptable strategy?
    Wong JSM; Tan GHC; Quek R; Goh BKP; Kwok LL; Kumar M; Soo KC; Teo MCC
    ANZ J Surg; 2017 Jun; 87(6):477-482. PubMed ID: 27226158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological features and treatment outcome of oesophageal gastrointestinal stromal tumour (GIST): A large, retrospective multicenter European study.
    Mohammadi M; IJzerman NS; Hohenberger P; Rutkowski P; Jones RL; Martin-Broto J; Gronchi A; Schöffski P; Vassos N; Farag S; Baia M; Oosten AW; Steeghs N; Desar IME; Reyners AKL; van Sandick JW; Bastiaannet E; Gelderblom H; Schrage Y
    Eur J Surg Oncol; 2021 Aug; 47(8):2173-2181. PubMed ID: 33895019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical characteristics and prognosis analysis of 119 cases with giant gastrointestinal stromal tumor].
    Zhang P; Zeng X; Gao J; Liu W; Shuai X; Liu K; Liu X; Cai M; Cai K; Wang G; Tao K
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1290-1295. PubMed ID: 27928802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A model to predict the recurrence of middle-high risk gastrointestinal stromal tumors based on preoperative fibrinogen and peripheral blood inflammatory indexes].
    Li W; Peng QW; Lin Y; Wan WZ; Zeng XY; Sun X; Yang WC; Xiong Z; Liu WZ; Tao KX; Zhang P
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep; 23(9):896-903. PubMed ID: 32927515
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinicopathological features and prognosis of gastrointestinal stromal tumor with PDGFRA-D842V mutation].
    Li XQ; Tu L; Wang M; Ma XL; Yang LX; Shen YY; Zhuang C; Zhao WY; Qiu JF; Zhao G; Cao H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep; 23(9):872-879. PubMed ID: 32927512
    [No Abstract]   [Full Text] [Related]  

  • 20. Surgical therapy for gastrointestinal stromal tumours of the upper gastrointestinal tract.
    Das A; Wilson R; Biankin AV; Merrett ND
    J Gastrointest Surg; 2009 Jul; 13(7):1220-5. PubMed ID: 19370382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.